{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2008"],"condition":["Metastatic Colorectal Cancer","Colorectal cancer","Colorectal Neoplasms","Cancer"],"disease":["Metastatic Colorectal Cancer","Colorectal Cancer","Colorectal Neoplasms","Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2046754"],"location":["Canada","United States"],"study_start_month":["3"],"keyword":["Irinotecan","Chemotherapy","Epidermal growth factor","Panitumumab","Metastatic","EGFr"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Effect of Panitumumab on the Pharmacokinetics of Irinotecan","description":"The primary objective of this study is to determine if panitumumab affects the pharmacokinetic (PK) profile of irinotecan.","dates":{"creation":"2008-03-15"},"accession":"2046754","cross_references":{"ClinicalTrials___gov":["NCT00563316"]}}